跳至主要内容
临床试验/IRCT20170325033132N3
IRCT20170325033132N3已完成2 期

Comparison of the effectiveness of nebulized Budezonide (pulmicort) versus placebo in the treatment of adult with moderate to severe acute asthma referring to Dr Shariati and Sina hospitals from 2017 to 2018

Astra Zeneca0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age > 18 with signed informed consent letter
  • Patients with acute asthma(moderate to severe)

排除标准

  • Unwillingness of patients to participate in the study
  • Patients with COPD
  • Pneumothorax
  • Acute and severe respiratory failure with cyanosis and confusion
  • Loss of consciousness
  • Pregnant patients
  • Intubated patients and patients with unstable vital signs
  • New case of asthma
  • Hemodynamic instability

研究者

发起方
Astra Zeneca

相似试验